The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty
| Status: | Completed |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 4/2/2016 |
| Start Date: | June 2009 |
| End Date: | December 2011 |
| Contact: | Anto Fritz, M D |
| Email: | atfritz@ucdavis.edu |
| Phone: | 925 785 0826 |
The investigators hypothesize that Arixtra patients will be less likely to experience wound
infection than patients who have received low-molecular weight heparin, coumadin or aspirin
with mechanical compression.
infection than patients who have received low-molecular weight heparin, coumadin or aspirin
with mechanical compression.
Inclusion Criteria:
- All primary unilateral TKA and THA cases will be included.
Exclusion Criteria:
- Patients less than 50 kg, Patients with CrCl<30ml/min. Revision and bilateral
procedures will be excluded.
We found this trial at
1
site
Click here to add this to my saved trials
